E. DOĞAN Et Al. , "Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.4, pp.781-786, 2020
DOĞAN, E. Et Al. 2020. Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.4 , 781-786.
DOĞAN, E., FIRAT, S. T., COŞAR, R., BOZKURT, O., İNANÇ, M., & ÖZKAN, M., (2020). Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.4, 781-786.
DOĞAN, ENDER Et Al. "Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.4, 781-786, 2020
DOĞAN, ENDER Et Al. "Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.4, pp.781-786, 2020
DOĞAN, E. Et Al. (2020) . "Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.4, pp.781-786.
@article{article, author={ENDER DOĞAN Et Al. }, title={Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={781-786} }